Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China
· Delayed Price · Currency is CNY 22.42
-0.50 (-2.18%)
Apr 24, 2025, 2:45 PM CST
SHA:688298 Revenue
In the year 2024, Zhejiang Orient Gene Biotech had annual revenue of 826.71M CNY with 0.80% growth. Zhejiang Orient Gene Biotech had revenue of 169.09M in the quarter ending December 31, 2024, with 0.66% growth.
Revenue
826.71M
Revenue Growth
+0.80%
P/S Ratio
5.36
Revenue / Employee
370.55K
Employees
2,231
Market Cap
4.43B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |